- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02938897
Telenutrition Weight Loss Study for Men
October 17, 2016 updated by: Melissa Ventura-Marra, West Virginia University
A Pilot Randomized Controlled Trial of a Home Telenutrition Weight Loss Program in Men
This study is a 12-week pilot randomized controlled trial to test the feasibility and effectiveness of a home telenutrition weight loss program in men in West Virginia.
Study Overview
Status
Completed
Conditions
Detailed Description
This study is a 12-week pilot randomized controlled trial of a home telenutrition weight loss program for men with obesity and at least one additional risk factor for cardiovascular disease. The primary aims are to:
- To assess the feasibility and acceptability of the male-targeted telenutrition weight loss program in terms of recruitment, retention and satisfaction and
- To evaluate the effectiveness of the telenutrition program compared to usual care (informational only) with regard to primary and secondary outcome measures at 12 weeks. We hypothesized that men receiving virtual and telephonic support from a registered dietitian nutritionist would have greater weight loss and greater improvements in diet quality than men who were only provided educational materials.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 40-70 year old man
- Body mass index ≥ 30
- Living with spouse or companion
- At least one of the following: hypertension, diabetes, pre-diabetes, hypercholesterolemia or hypertriglyceridemia
- A home computer with high-speed internet access
- A telephone for health coach phone calls
Exclusion Criteria:
- Cancer (except skin or prostate), celiac disease, bacterial or viral infections, renal or liver disease (except non-alcoholic fatty liver disease), or condition that prevents fruits and vegetable consumption
- Major surgery or health event (e.g., stroke, heart attack) in the past six months
- Taking insulin, anti-obesity medications, steroids (e.g., Prednisone), or warfarin (Coumadin)
- Pacemaker or defibrillator
- Currently on a weight loss diet or lost > 10 pounds in past six months
- Consume more than two alcoholic beverages daily
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telenutrition Intervention
Participants receive diet-related educational materials and self-monitoring tools PLUS registered dietitian nutritionist support.
|
RDN provided individualized medical nutrition therapy via videoconference at weeks 1, 5, and 9 and telephonic nutrition coaching support at weeks 2-4, 6-8, and 10-12.
Individualized caloric recommendations (500-750 kcal reduction) were made and food-based educational materials emphasizing general healthful eating patterns and increased intakes of nutrient-rich foods were provided.
Self-monitoring tools including: weekly weight log, fruit and vegetable tracker, and a SMART (specific, measurable, achievable, relevant, and time bound) goal planner were provided.
|
|
Active Comparator: Enhanced Usual Care Control
Participants receive diet-related educational materials and self-monitoring tools.
|
Individualized caloric recommendations (500-750 kcal reduction) were made and food-based educational materials emphasizing general healthful eating patterns and increased intakes of nutrient-rich foods were provided.
Self-monitoring tools including: weekly weight log, fruit and vegetable tracker, and a SMART (specific, measurable, achievable, relevant, and time bound) goal planner were provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Weight
Time Frame: Baseline to 12 weeks
|
Baseline to 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Waist Circumference
Time Frame: Baseline to 6 and 12 weeks
|
Baseline to 6 and 12 weeks
|
|
|
Change in Caloric Intake
Time Frame: Baseline to 6 and 12 Weeks
|
Baseline to 6 and 12 Weeks
|
|
|
Change in Diet and Diet Quality
Time Frame: Baseline to 6 and 12 Weeks
|
4-day food records, Healthy Eating Index-2010.
|
Baseline to 6 and 12 Weeks
|
|
Change in Body Composition
Time Frame: Baseline to 6 and 12 Weeks
|
Bioelectrical impedance analysis
|
Baseline to 6 and 12 Weeks
|
|
Health Related Quality of Life
Time Frame: Baseline and 12 Weeks
|
HRQOL-4
|
Baseline and 12 Weeks
|
|
Program Satisfaction
Time Frame: 6 and 12 Weeks
|
Questionnaire
|
6 and 12 Weeks
|
|
Program Usefulness
Time Frame: 6 and 12 Weeks
|
Questionnaire
|
6 and 12 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Melissa D Ventura-Marra, PhD, West Virginia University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
September 25, 2016
First Submitted That Met QC Criteria
October 17, 2016
First Posted (Estimate)
October 19, 2016
Study Record Updates
Last Update Posted (Estimate)
October 19, 2016
Last Update Submitted That Met QC Criteria
October 17, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1501549080
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will only be reported in aggregate.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Registered Dietitian Nutritionist (RDN) Support
-
Mayo ClinicCompletedIBS - Irritable Bowel SyndromeUnited States
-
Taipei Medical UniversityRecruitingType 2 Diabetes | M-health | AI-supported Real-time Dietary FeedbackTaiwan
-
Massachusetts General HospitalALS AssociationCompletedParkinson's Disease | Amyotrophic Lateral Sclerosis | Weight Loss | Cachexia | Huntington's Disease | Neurodegenerative DiseaseUnited States
-
Prince of Wales Hospital, SydneyCompleted
-
Zhejiang Cancer HospitalRecruitingHER2 Gene Mutation | Bile Duct Adenocarcinoma Non-ResectableChina
-
BiogenCompletedRelapsing Remitting Multiple SclerosisGermany
-
Arizona State UniversityCompletedIBS - Irritable Bowel SyndromeUnited States
-
Clalit Health ServicesHebrew University of JerusalemUnknown
-
medac GmbHCompleted